miR-138 exerts anti-glioma efficacy by targeting immune checkpoints
Jun Wei(Jilin Medical University), Amy B. Heimberger(Northwestern University), George A. Călin(The University of Texas MD Anderson Cancer Center), Konrad Gabrusiewicz(Cell Medica (Switzerland)), Edjah K. Nduom(The University of Texas MD Anderson Cancer Center), Fei Wang(University of Missouri), Shuo Xu(The University of Texas MD Anderson Cancer Center), Ali Alum(The University of Texas MD Anderson Cancer Center), Ling‐Yuan Kong(The University of Texas MD Anderson Cancer Center), Gregory N. Fuller(The University of Texas MD Anderson Cancer Center)
Cited by 11
Related Papers
Noncoding RNA therapeutics — challenges and potential solutions
|Nature Reviews Drug Discovery|2021|1.5k
Non-coding RNAs in disease: from mechanisms to therapeutics
|Nature Reviews Genetics|2023|779
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
|Neuro-Oncology|2010|708
Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis
|Nature Immunology|2016|487
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
|JCI Insight|2016|454